greeksoup/ stock research
Stock research / United States / SNY / Year to 31 December 2018

Sanofi (SNY) annual results, year to 31 December 2018: revenue EUR 34,463 million, from the 20-F

Sanofi files a 20-F with the SEC once a year, in euros. In the year to 31 December 2018 it reported revenue from the sale of goods of EUR 34,463 million ($40.7 billion at the year's average rate), down 1.7% on the year before. Its profit attributable to shareholders was EUR 4,306 million, down 48.8%, and diluted earnings per share EUR 3.43.

Revenue
EUR 34,463 million
-1.7% on the year
FY2015FY2018
Operating margin
13.6%
16.5% a year earlier
FY2015FY2018
Net income
EUR 4,306 million
-48.8% on the year
FY2015FY2018
Diluted EPS
EUR 3.43
-48.3% on the year
FY2015FY2018

this yearthe year beforeIn euros as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2017 †Dec 2018
Revenue from the sale of goods35,07234,463
Cost of sales11,61311,435
Gross profit24,60824,242
Research and development5,4725,894
Selling, general and administrative10,0729,859
Operating profit5,8044,676
Finance costs420435
Income tax1,722481
Profit for the year8,5374,410
Profit attributable to shareholders8,4164,306
Filing20-F20-F
EUR million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toDec 2017 †Dec 2018
Diluted EPS6.643.43
Basic EPS6.703.45
Filing20-F20-F

EUR per ordinary share, as filed.

Cash flow

Year toDec 2017 †Dec 2018
Cash from operations7,3795,547
Cash from investing-2,896-12,866
Cash from financing-7,9023,934
Buybacks2,1621,101
Dividends paid3,7103,773
Filing20-F20-F

EUR million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2017 †Dec 2018
Funded by
Equity attributable to shareholders58,07058,876
Non-controlling interests169159
Borrowings, as filed15,46824,586
Other liabilities26,10627,787
Total equity and liabilities99,813111,408
Owned
Property, plant and equipment9,5799,651
Goodwill40,26444,235
Other intangible assets13,08021,889
Cash and cash equivalents10,3156,925
Inventories6,8187,477
Other assets19,75721,231
Total assets99,813111,408
Filing20-F20-F

EUR million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2017 †Dec 2018
Return on year-end equity14.5%7.3%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2018, filed 4 March 2021: the filing. The figures are in euros as filed.